Fremman Capital

Fremman Capital is a pan-European mid-market investment firm established in 2020, with offices in London, Madrid, Paris, Munich, Milan, and Luxembourg. The firm focuses on partnering with successful founders and management teams to help them transform their businesses from local champions into multinational sustainable leaders. Their investment strategy is centered around three core values: to assist, to promote, and to accomplish, aiming to build better, more sustainable businesses that have a positive impact on society.

The firm's investment approach is multi-sector, targeting industries such as Business & Tech Services, Healthcare, Consumer Goods & Distribution, and Industrials. They seek to invest in market-leading businesses in long-term and often highly fragmented industries, focusing on essential products and services. Fremman Capital operates across Western Europe, leveraging its extensive network and expertise to access unique investment opportunities.

Since its inception, Fremman Capital has made several notable investments, including the acquisition of a majority stake in Italian specialty In Vitro Diagnostics leader DIESSE Diagnostica Senese in January 2025, and the acquisition of a majority stake in outpatient rehabilitation specialist rehaneo in November 2024. These investments reflect Fremman Capital's commitment to partnering with management teams to drive sustainable growth and create long-term value across Europe.